Events
Upcoming Events
There are no upcoming events
Past Events
ASCO 2021
Abstract Title: A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors
Oral Abstract Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Session Date & Time: Friday, June 4, 2021 at 11:00 AM ET
Abstract ID: 3000
AACR 2021 Virtual Annual Meeting
Minisymposium (Oral presentation): RBN-2397: A potent and selective small molecule inhibitor of PARP7 that induces tumor-derived antitumor immunity dependent on CD8 T cells
Presentation | Video
April 11, 2021, 2:00p.m. EDT
Poster: Elevated PARP7 expression in select cancers identifies a target population for RBN-2397 therapy
Poster | Audio
April 10, 2021, 8:30 a.m.
Poster: Investigating the mechanism of PARP7 inhibition in Type I interferon signaling by arrayed CRISPR screening
Poster | Audio
April 10, 2021, 8:30 a.m.
Poster: Targeted degradation of PARP14 using a heterobifunctional small molecule
Poster | Audio
April 10, 2021, 8:30 a.m.
Poster: Small molecule inhibitor of CD38 modulates its intra- and extracellular functions leading to antitumor activity
Poster | Audio
April 10, 2021, 8:30 a.m.
PARP & DDR Inhibitors Digital Summit 2021
Seminar: A Bespoke Screening Platform to Study Mono (ADP-ribosylation).
Presentation | Video
Jan 27, 2021 at 10:30 a.m. EST
AACR Virtual Meeting II – June 22-24, 2020
Minisymposium (oral presentation): PARP7 negatively regulates the Type I interferon response in cancer cells and its inhibition leads to tumor regression
Presentation | Video
June 23, 2020, 9:00 – 11:00 a.m. EDT
Poster: A multi-omic characterization of PARP enzymes in cancer to identify novel monoPARP drug targets
Poster | Audio
June 22, 2020, 9:00 a.m. – 6:00 p.m. EDT
Poster: A bespoke screening platform to study mono(ADP-ribosylation)
Poster | Audio
June 22, 2020, 9:00 a.m. – 6:00 p.m. EDT
31st Annual Cancer Progress Conference – May 5-6, 2020
Panel: Paradigm-shifting Platforms II, Non-IO: Targeting Better, Targeting the Intractable
May 5, 2020 at 11:45 a.m. EDT
Listen to webcast
Bank of America Securities 2020 HealthCare Conference – May 12-14, 2020
Corporate Presentation
May 12, 2020 at 5 p.m. EDT
American Association of Cancer Research (AACR) Virtual Annual Meeting I – April 27-28, 2020
Oral Presentation: RBN-2397 – A First-in-Class PARP7 Inhibitor Targeting a Newly Discovered Cancer Vulnerability in Stress-Signaling Pathways.
Presentation | Video
April 28, 2020 at 10:50 a.m. EDT
Oral Presentation: RBN012759 – A Potent and Selective PARP14 Inhibitor Decreases Pro-tumor Macrophage Function and Elicits Inflammatory Responses in Tumor Explants.
Presentation | Video
April 27, 2020 at 12:20 p.m. EDT
PARP & DDR Inhibitors Summit – Jan. 28-30, 2020
Presentation: Not all PARPs are Alike: Exploring the Therapeutic Potential of PARPi Beyond PARP1 Inhibitors
Jan. 29, 2020
SLAS 2020 International Conference and Exhibition – Jan. 25-29, 2020
Podium presentation: A Bespoke Screening Platform to Study mono (ADP-ribosylation)
Jan. 29, 2020
Poster presentation: Development of Novel Biochemical Assays for the Screening of MonoPARP Enzymes
Jan. 28, 2020